Second Iranian Vaccine Gets Emergency Use Approval

Iran’s Health Ministry authorized the emergency use of another homegrown coronavirus vaccine developed by the Pasteur Institute, Health Minister Saeed Namaki said.
Namaki said on Tuesday that the vaccine developed by the Pasteur Institute of Iran had obtained the emergency use approval after successfully completing various trial stages, ISNA reported.
“The third phase of the clinical trial for the Pasteur vaccine, which is the second Iranian vaccine against coronavirus, has been carried out and today we were able to obtain the permission for its emergency use form the legal committee,” he said.
Iran had approved its flagship COVIran Barekat vaccine for emergency use earlier this month. The Pasteur vaccine has been developed as part of a joint project with Cuban scientists.
The approvals come as the government seeks to accelerate its inoculation program against the coronavirus some six months after it began using supplies from other countries.
The campaign has mostly relied on Russian and Chinese jabs and others provided by a World Health Organization project.
Iran has other coronavirus vaccine candidates, including two being developed by scientists in the armed forces and one by the Razi Vaccine and Serum Research Institute.